Independent Wealth Network Inc. Sells 110 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Independent Wealth Network Inc. lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,532 shares of the financial services provider’s stock after selling 110 shares during the quarter. Independent Wealth Network Inc.’s holdings in iShares Biotechnology ETF were worth $467,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of IBB. BNP Paribas Financial Markets grew its position in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after acquiring an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after buying an additional 164,000 shares during the period. Aprio Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth $18,476,000. Aristides Capital LLC purchased a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth $9,180,000. Finally, Sanctuary Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth $8,118,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.1 %

Shares of IBB stock opened at $136.29 on Thursday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The stock has a fifty day simple moving average of $136.00 and a two-hundred day simple moving average of $141.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.